There is mounting evidence that the neuropeptide oxytocin is a possible candidate for the
treatment of drug addiction. Oxytocin was shown to reduce methamphetamine self …

There is emerging evidence that the neuropeptide oxytocin may be utilised as a treatment
for various psychopathologies, including drug addictions. Here we used an animal model to …

Recent preclinical evidence indicates that the neuropeptide oxytocin may have potential in
the treatment of drug dependence and drug withdrawal. Oxytocin reduces …

The neuropeptide oxytocin plays a role in reward, stress, social affiliation, learning, and
memory processes. As such, there is increasing interest in oxytocin as a potential treatment …

The role of oxytocin in attenuating the abuse of licit and illicit drugs, including the
psychostimulant methamphetamine, has been examined with increased ferocity in recent …

The neuropeptide oxytocin has shown promise as an effective therapy in pre-clinical models
of methamphetamine (METH) addiction. The nucleus accumbens core (NAcc) has been …

The neuropeptide oxytocin attenuates reward and abuse for the psychostimulant
methamphetamine (METH). Recent findings have implicated the nucleus accumbens (NA c) …

Animal and human evidence supports a role for oxytocin in alcohol-seeking behaviors.
There is interest, therefore, in targeting the oxytocin pathway as a new pharmacologic …

Growing research indicates oxytocin may be involved in relieving anxiety and attenuating
the rewarding effects of psychostimulants. This study investigated the effects of subchronic …

Background: Oxytocin, a neurohypophyseal neuropeptide, is a potential mediator and
regulator of drug addiction. However, the cellular mechanisms of oxytocin in drug seeking …